Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-14T04:36:30.645Z Has data issue: false hasContentIssue false
  • English
  • Français

Shigella species from Addis Ababa: frequency of isolation and in vitro drug sensitivity

Published online by Cambridge University Press:  25 March 2010

Messele Gedebou  and
Alebachew Tassew
Messele Gedebou
Affiliation:
Department of Medical Microbiology and Parasitology, Faculty of Medicine, Addis Ababa University, P.O. Box 1176, Addis Ababa, Ethiopia
Alebachew Tassew
Affiliation:
Department of Medical Microbiology and Parasitology, Faculty of Medicine, Addis Ababa University, P.O. Box 1176, Addis Ababa, Ethiopia
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

One hundred and five shigella isolates from Addis Ababa were studied to determine serogroup frequency and in vitro antibacterial drug sensitivity.

About 70 % of the isolates were Shigella Flexneri followed by Sh. dysenteriae (15%), Sh. boydii (10%) and Sh. sonnei (5%). All or most of the strains were susceptible to cephalothin, gentamicin, kanamycin, polymyxin B and trimetho-primsulphamethoxazole. Frequencies of susceptibility to ampicillin, carbenicillin and chloramphenicol were, respectively, 79, 80 and 75%. Only 37, 23 and 58% were susceptible to streptomycin, sulphadiazine and tetracycline, respectively.

Resistance to one or more drugs was detected in 85 % while 72 % were multiply resistant. There were 24 different resistance patterns, varying from resistance to one drug to resistance to seven drugs.

The findings have been compared with reports from other countries. This study and several others cited support the view that trimethoprim-sulphamethoxazole is the best alternative drug for treatment of shigellosis particularly in regions with multiple drug-resistant strains.

Type
Research Article
Information
Journal of Hygiene , Volume 88 , Issue 1 , February 1982 , pp. 47 - 55
Copyright
Copyright © Cambridge University Press 1982

References

Aoki, Y. (1968). Serological groups of Shigella in Japan and neighboring countries. A review. Tropical Medicine 10, 116–126.Google Scholar
Aoki, Y., Naito, T.Fujise, X., Miura, K., Iwanaga, Y., Ikeda, A., Jinnouchi, K., Morino, T., Miyahara, A., Motoki, Y. & Tokiwa, H. (1969). Colicin type, biochemical type and drug resistance pattern of Shigella sonnei isolated in Japan and its neighboring countries; a detailed report. Tropical Medicine 11, 57–74.Google Scholar
Bauer, A. W., Kirby, W. M. M., Sherris, J. C. & Turk, M. (1966). Antibiotic susceptibility testings by a standardized single disc method. American Journal of Clinical Pathology 45, 493–496.CrossRefGoogle Scholar
Byers, P. A.. Dupont, H. L. & Goldschmidt, M. C. (1976). Antimicrobial susceptibilities of Shigellae isolated in Houston. Texas, in 1974. Antimicrobial Agents and Chemotherapy 9, 288–291.CrossRefGoogle ScholarPubMed
Chang, M. J., Dunkel, L. M., Reken, D. V., Anderson, D., Wong, M. L. & Feigin, R. D. (1977). Trimethoprim-sulfame thoxazole compared to ampicillin in the treatment of Shigellosis. Pediatrics 59, 726–729.CrossRefGoogle Scholar
Chun, D. & Seol, S. Y. (1978). Drug resistance and R plasmids of Salmonella and Shigella in Korea. Tropical Medicine 20, 123–129.Google Scholar
Controni, G., Friedman, G. & Ficke, M. (1978). Update of Shigella gastroenteritis: Changing patterns of antibiotic resistance. 1964–1976. In Current Chemotherapy. Proceedings of the 10th International Congress of Chemotherapy, vol. I (ed. Siegenthaler, W. and Luthy, R.), pp. 169–171. Washington D.C.: American Society for Microbiology.Google Scholar
Datta, M. & Olarte, J. (1974). R factors in strains of Salmonella typhi and Shigella dysenteriae 1 isolated during epidemics in Mexico: classification by compatibility. Antimicrobial Agents and Chemotherapy 5, 310–317.CrossRefGoogle ScholarPubMed
Daviks, J. R., Farrant, W. N. & Uttley, A. H. C. (1970). Antibiotic resistance of Shigella Honnei. Lancet ii, 1157–1159.Google Scholar
Edwards, P. R. & Ewing, W. H. (1972). Identification of Enterobacteriaceae, 3rd ed.Minneapolis, Minn.: Burgess Publishing Company.Google Scholar
Farrar, W. E. & Dekle, L. C. (1967). Transferable antibiotic resistance associated with an outbreak of shigellosis. Annals of Internal Medicine 67, 1208–1215.CrossRefGoogle Scholar
Farrar, W. E. & Eidson, M. (1971). Antibiotic resistance in Shigella mediated by R factors. Journal of Infectious Diseases 123, 477–484.CrossRefGoogle ScholarPubMed
Frazen, C., Lidin-Janson, G. & Nygren, B. (1972). Trimethoprim-sulfamethoxazole in enteric infections. Scandinavian Journal of Infectious Diseases 4, 231–240.CrossRefGoogle Scholar
Gangarosa, E. J., Bennett, J. V., Wyatt, C., Pierce, P. E., Olarte, J., Mendoza-Hernandez, P. & Vazquez, V. (1972). An epidemic associated episome? Journal of Infectious Disease 126, 215–218.CrossRefGoogle ScholarPubMed
Gebre-Yohannes, A. & Limenih, Y. (1980). Multiple drug resistance within Shigella serogroups. Ethiopian Medical Journal 18, 7–14.Google ScholarPubMed
Gedebou, M. & Tassew, A. (1979). Antibiotic susceptibility patterns and R factor among Salmonella and Shigella isolates. Abstract. Ethiopian Medical Journal 17, 99–100.Google Scholar
Gedebou, M., Tassew, A. & Akalu, T. (1977). Bacterial isolates at Black Lion Hospital: their frequency of isolation and drug susceptibility patterns. Abstract. Ethiopian Medical Journal 15, 123–124.Google Scholar
Gillies, R. R. (1964). Colicin production as an epidemiological marker of Shigella sonnei. Journal of Hygiene 62, 1–9.CrossRefGoogle ScholarPubMed
Gordon, R. C.. Thompson, T. R., Carlson, W., Dyke, J. W. & Stevens, L. I. (1975). Anti-microbial resistance of Shigellae isolated in Michigan. Journal of the American Medical Association 231, 1159–1161.CrossRefGoogle Scholar
Jarvis, D. J. & Scrimgeour, G. (1970). In vitro sensitivity of Shigella sonnei to trimethoprim and sulfamethoxazole. Journal of Medical Microbiology 3, 554–557.Google Scholar
Lexomboon, U., Mansuan, P., Duangmani, C., Benjadol, P. & McMilnn, M. T. (1972). Clinical evaluation of co-trimoxazole and furazolidone in treatment of Shigellosis in children. British Medical Journal 3, 23–26.CrossRefGoogle ScholarPubMed
Martin, D. G., Tong, M. J., Ewald, P. E. & Kelly, A. V. (1970). Antibiotic sensitivities of Shigella isolates in Vietnam 1968–69. Military Medicine 135, 560–562.CrossRefGoogle Scholar
Mata, L. J., Gangarosa, E. J., Caceres, A., Perera, D. R. & Mejicanos, M. L. (1970). Epidemic Shiga bacillus dysentery in Central America. I. Etiologic investigation in Guatemala, 1969. Journal of Infectious Diseases 122, 170–180.CrossRefGoogle ScholarPubMed
Matsen, J. M. & Barry, A. L. (1974). Susceptibility testing: diffusion teat procedures. In Manual of Clinical Microbiology, 2nd ed. (ed. Lennette, E. H., Spaulding, E. H. and Truant, J. P.), p. 421. Washington, D.C.: American Society for Microbiology.Google Scholar
Mero, E. (1976). Resistance to antibiotics of Shigella strains isolated in Somalia. Bulletin of the World Health Organization 54, 473–474.Google ScholarPubMed
Mitsuhashi, S. (1969). The R factors. Journal of Infectious Diseases 119, 89–100.CrossRefGoogle ScholarPubMed
Nelson, J. D., Kusmiesz, H., Jackson, L. H. & Woodman, E. (1976). Trimethoprim-sulfamethoxazole therapy for shigellosis. Journal of the American Medical Association 235, 1239–1243.CrossRefGoogle ScholarPubMed
Neu, H. C., Cherubin, C. E., Longo, E. D. & Winter, J. (1975). Antimicrobial resistance of Shigella isolated in New York City in 1973. Antimicrobial Agents and Chemotherapy 7, 833–839.CrossRefGoogle ScholarPubMed
Olarte, J., Filloy, L. & Galindo, E. (1976). Resistance of Shigella dysenteriae type 1 to ampicillin and other antimicrobial agents: strains isolated during a dysentery outbreak in a hospital in Mexico City. Journal of Infectious Diseases 133, 572–575.CrossRefGoogle Scholar
Reller, L. B., Gangarosa, E. J. & Brachman, P. S. (1970). Shigellosis in the United States: Five year review of nationwide surveillance, 1964–1968. American Journal of Epidemiology 91, 161–169.CrossRefGoogle ScholarPubMed
Rodriquez, W. J., Khan, W. N., Ross, S., Controni, G. & Goldenberg, R. (1978). Trimethoprim-sulfamethoxazole in shigellosis.In Current Chemotherapy. Proceedings of the 10th International Congress of Chemotherapy, vol. 1 (ed. Siegenthaler, W. and Luthy, R.). p. 172–175. Washington, D.C.: American Society for Microbiology.Google Scholar
Ross, S., Controni, G. & Khan, W. (1972). Resistance of Shigellae to ampicillin and other antibiotics. Its clinical and epidemiological implications. Journal of the American Medical Association 221, 45–47.CrossRefGoogle ScholarPubMed
Salzman, T. C., Scher, C. D. & Moss, R. (1967). Shigellae with transferable drug resistance: outbreak in a nursery for premature infants. Journal of Pediatrics 71, 21–26.CrossRefGoogle Scholar
Smith, J. T.. Bremner, D. A. & Datta, N. (1974). Ampicillin resistance of Shigella sonnei. Antimicrobial Agents and Chemotherapy 6, 418–421.CrossRefGoogle ScholarPubMed
Urban, T. (1972). Transferable multiple drug resistance of Shigella strains isolated in Sweden. Scandinavian Journal of Infectious Diseases 4, 221–227.CrossRefGoogle ScholarPubMed